393 related articles for article (PubMed ID: 32053261)
1. A Metal-Organic Framework (MOF) Fenton Nanoagent-Enabled Nanocatalytic Cancer Therapy in Synergy with Autophagy Inhibition.
Yang B; Ding L; Yao H; Chen Y; Shi J
Adv Mater; 2020 Mar; 32(12):e1907152. PubMed ID: 32053261
[TBL] [Abstract][Full Text] [Related]
2. Metal-Organic Framework-Based Nanoagents for Effective Tumor Therapy by Dual Dynamics-Amplified Oxidative Stress.
Chen J; Wang Y; Niu H; Wang Y; Wu A; Shu C; Zhu Y; Bian Y; Lin K
ACS Appl Mater Interfaces; 2021 Sep; 13(38):45201-45213. PubMed ID: 34525803
[TBL] [Abstract][Full Text] [Related]
3. Nano-Fenton Reactors as a New Class of Oxidative Stress Amplifying Anticancer Therapeutic Agents.
Kwon B; Han E; Yang W; Cho W; Yoo W; Hwang J; Kwon BM; Lee D
ACS Appl Mater Interfaces; 2016 Mar; 8(9):5887-97. PubMed ID: 26888039
[TBL] [Abstract][Full Text] [Related]
4. Ultrasmall Cu
Hu R; Fang Y; Huo M; Yao H; Wang C; Chen Y; Wu R
Biomaterials; 2019 Jun; 206():101-114. PubMed ID: 30927714
[TBL] [Abstract][Full Text] [Related]
5. Synergistic Amplification of Oxidative Stress-Mediated Antitumor Activity via Liposomal Dichloroacetic Acid and MOF-Fe
Sun L; Xu Y; Gao Y; Huang X; Feng S; Chen J; Wang X; Guo L; Li M; Meng X; Zhang J; Ge J; An X; Ding D; Luo Y; Zhang Y; Jiang Q; Ning X
Small; 2019 Jun; 15(24):e1901156. PubMed ID: 31074196
[TBL] [Abstract][Full Text] [Related]
6. Engineering 2D Cu-composed metal-organic framework nanosheets for augmented nanocatalytic tumor therapy.
Zhuang S; Xiang H; Chen Y; Wang L; Chen Y; Zhang J
J Nanobiotechnology; 2022 Feb; 20(1):66. PubMed ID: 35120548
[TBL] [Abstract][Full Text] [Related]
7. Nanocatalysts-Augmented and Photothermal-Enhanced Tumor-Specific Sequential Nanocatalytic Therapy in Both NIR-I and NIR-II Biowindows.
Feng W; Han X; Wang R; Gao X; Hu P; Yue W; Chen Y; Shi J
Adv Mater; 2019 Feb; 31(5):e1805919. PubMed ID: 30536723
[TBL] [Abstract][Full Text] [Related]
8. Photonic/magnetic hyperthermia-synergistic nanocatalytic cancer therapy enabled by zero-valence iron nanocatalysts.
Dai C; Wang C; Hu R; Lin H; Liu Z; Yu L; Chen Y; Zhang B
Biomaterials; 2019 Oct; 219():119374. PubMed ID: 31369897
[TBL] [Abstract][Full Text] [Related]
9. Programmed Catalytic Therapy-Mediated ROS Generation and T-Cell Infiltration in Lung Metastasis by a Dual Metal-Organic Framework (MOF) Nanoagent.
Nirosha Yalamandala B; Chen PH; Moorthy T; Huynh TMH; Chiang WH; Hu SH
Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335903
[TBL] [Abstract][Full Text] [Related]
10. Nanocatalysts-augmented Fenton chemical reaction for nanocatalytic tumor therapy.
Qian X; Zhang J; Gu Z; Chen Y
Biomaterials; 2019 Aug; 211():1-13. PubMed ID: 31075521
[TBL] [Abstract][Full Text] [Related]
11. Metabolism-Regulating Nanozyme System for Advanced Nanocatalytic Cancer Therapy.
Liu C; Xu X; Chen Y; Yin M; Mäkilä E; Zhou W; Su W; Zhang H
Small; 2024 Jun; 20(24):e2307794. PubMed ID: 38168483
[TBL] [Abstract][Full Text] [Related]
12. Triggering Sequential Catalytic Fenton Reaction on 2D MXenes for Hyperthermia-Augmented Synergistic Nanocatalytic Cancer Therapy.
Liang R; Li Y; Huo M; Lin H; Chen Y
ACS Appl Mater Interfaces; 2019 Nov; 11(46):42917-42931. PubMed ID: 31635454
[TBL] [Abstract][Full Text] [Related]
13. Anti-VEGFR2-labeled enzyme-immobilized metal-organic frameworks for tumor vasculature targeted catalytic therapy.
Zhou J; Wang K; Ding S; Zeng L; Miao J; Cao Y; Zhang X; Tian G; Bian XW
Acta Biomater; 2022 Mar; 141():364-373. PubMed ID: 35063709
[TBL] [Abstract][Full Text] [Related]
14. Hydroxyl radical (·OH) played a pivotal role in oridonin-induced apoptosis and autophagy in human epidermoid carcinoma A431 cells.
Yu Y; Fan SM; Song JK; Tashiro S; Onodera S; Ikejima T
Biol Pharm Bull; 2012; 35(12):2148-59. PubMed ID: 23207767
[TBL] [Abstract][Full Text] [Related]
15. Bimetallic Metal-Organic Frameworks: Enhanced Peroxidase-like Activities for the Self-Activated Cascade Reaction.
Zhao X; Zhang N; Yang T; Liu D; Jing X; Wang D; Yang Z; Xie Y; Meng L
ACS Appl Mater Interfaces; 2021 Aug; 13(30):36106-36116. PubMed ID: 34313120
[TBL] [Abstract][Full Text] [Related]
16. Highly efficient Fenton and enzyme-mimetic activities of NH
He J; Zhang Y; Zhang X; Huang Y
Sci Rep; 2018 Mar; 8(1):5159. PubMed ID: 29581533
[TBL] [Abstract][Full Text] [Related]
17. Endogenous Copper for Nanocatalytic Oxidative Damage and Self-Protection Pathway Breakage of Cancer.
Guo Y; Xu Y; Bao Q; Shen C; Ni D; Hu P; Shi J
ACS Nano; 2021 Oct; 15(10):16286-16297. PubMed ID: 34652919
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria-mediated self-cycling nanoreactor enabling uninterrupted oxidative damage for enhanced chemodynamic therapy.
Wu S; Wang H; Wei Y; Kang L; Cui T; Huang Y; Liu Z; Pu F; Ren J
Colloids Surf B Biointerfaces; 2024 Aug; 240():113990. PubMed ID: 38810468
[TBL] [Abstract][Full Text] [Related]
19. Extracellular-vesicles delivered tumor-specific sequential nanocatalysts can be used for MRI-informed nanocatalytic Therapy of hepatocellular carcinoma.
Wu H; Xing H; Wu MC; Shen F; Chen Y; Yang T
Theranostics; 2021; 11(1):64-78. PubMed ID: 33391461
[No Abstract] [Full Text] [Related]
20. Acidic pH and High-H
Lin B; Chen H; Liang D; Lin W; Qi X; Liu H; Deng X
ACS Appl Mater Interfaces; 2019 Mar; 11(12):11157-11166. PubMed ID: 30869853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
